Sunesis: About Sunesis

Sunesis is an emerging biopharmaceutical company creating new medicines to improve the lives of people with cancer. We are building a pipeline of drugs that selectively block critical mechanisms required for tumor growth and survival. The fight against cancer is an enormous mission that requires an integrated approach fueled by a commitment to innovation.

Innovation

Innovation is essential to advancing strategies for treating disease. Learn the role innovation plays in our drive to develop high-impact medicines for cancer patients.

Commitment

We are in this business because we believe we can make a difference. Read about our commitment to improving the lives of people with cancer and their loved ones.

Strategy

A focused strategy helps us develop ideas, bring them to market, and expand our capacity.

Leadership

We have the expertise, background, and passion to build a fully integrated company that both creates shareholder value and improves cancer care. Learn about our leadership team.

History

Learn about our company's history from our start in 1998, to the development of our specialized discovery platform, to the molecules currently in testing.

Sunesis has a pipeline of innovative therapeutics in various stages of development and testing.

Strategic alliances allow us to expand our discovery, development and marketing efforts.